THE NEW HOPE FOR WEIGHT CONTROL ?

Researchers are excitedly examining retatrutide, a novel drug from Eli Lilly, as a possible breakthrough in weight reduction . Unlike many earlier approaches, retatrutide is a double -action agonist targeting simultaneously GLP-1 and GIP, hormones that impact satiety and blood glucose control . E